郭燕华 罗陆一 杨焕斌.复方丹参滴丸治疗冠心病心绞痛临床观察[J].实用中西医结合临床,2006,(3):7-8 |
复方丹参滴丸治疗冠心病心绞痛临床观察 |
|
|
DOI: |
中文关键词: 冠状动脉疾病 心绞痛 复方丹参滴丸 临床观察 |
英文关键词: FuFangDanShenDiWan Angina pectoris Clinical Observation Coronary artery disease |
基金项目: |
|
摘要点击次数: 589 |
全文下载次数: 289 |
中文摘要: |
目的:观察复方丹参滴丸治疗冠心病心绞痛的疗效。方法:用单硝酸异山梨酯作为对照,服药前后记录心绞痛症状、心电图ST-T改变、动态心电图缺血性ST-T改变的时间、血黏和血脂的情况。结果:复方丹参滴丸治疗后,病人心绞痛总有效率为94%,心电图改善总有效率为72%,动态心电图缺血性ST-T改变的时间(分钟)由(115.45±12.34)改善为(15.28±2.32),与单硝酸异山梨酯治疗的对照组相比,有明显差异(P <0.05)。结论:复方丹参滴丸治疗冠心病心绞痛疗效明显,且没有任何的毒副作用。 |
英文摘要: |
Objective:To observe the therapeutic efficacy of FuFangDanShenDiWan in patients with angina pectoris. Methods: 50 patients with angina pectoris were treated by FuFangDanShenDiWan and the symptoms, ECG (ischemic ST-T changes),holter ECG,blood viscosity and blood fat were recorded. Results: The total efficacy of FuFangDanShenDiWan to the improving of Angina Pectoris amounted to 94%, that to the improving of ECG amounted to 72 %,the improving time (minutes) of holter ECG from (115.45±12.34) to(15.28±2.32).The therapeutic efficacy of FuFangDanShenDiWan is higher than isosorbidi mononitratis with significant difference between these two drugs (P <0.05). Conclusion: FuFangDanShenDiWan is useful to the treatment of angina pectoris and without any side effect. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |